{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T21:26:57Z","timestamp":1760909217888,"version":"3.44.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"2-3","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,29]],"date-time":"2021-05-29T00:00:00Z","timestamp":1622246400000},"content-version":"am","delay-in-days":362,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales d'Endocrinologie"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.ando.2020.04.002","type":"journal-article","created":{"date-parts":[[2020,4,10]],"date-time":"2020-04-10T11:03:47Z","timestamp":1586516627000},"page":"124-125","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Multiple Endocrine Neoplasia Type 4: Novel CDNK1B variant and immune anomalies"],"prefix":"10.1016","volume":"81","author":[{"given":"B.","family":"Chevalier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.-F.","family":"Odou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Demonchy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Cardot-Bauters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9369-0463","authenticated-orcid":false,"given":"M.-C.","family":"Vantyghem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ando.2020.04.002_bib0055","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ando.2019.04.012","article-title":"Update on phenotypes of MEN1 mutation carriers","volume":"80","author":"Valk","year":"2019","journal-title":"Ann Endocrinol (Paris)"},{"key":"10.1016\/j.ando.2020.04.002_bib0060","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ando.2019.04.014","article-title":"Clinical utility of genetic diagnosis for sporadic and hereditary medullary thyroid carcinoma","volume":"80","author":"Elisei","year":"2019","journal-title":"Ann Endocrinol (Paris)"},{"issue":"9","key":"10.1016\/j.ando.2020.04.002_bib0065","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.1210\/jc.2019-00082","article-title":"Clinical features of multiple endocrine neoplasia type 4: novel pathogenic variant and review of published cases","volume":"104","author":"Frederiksen","year":"2019","journal-title":"J Clin Endocrinol Metabol"},{"issue":"1","key":"10.1016\/j.ando.2020.04.002_bib0070","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ajhg.2012.11.018","article-title":"Meta-analysis Followed by Replication Identifies Loci in or near CDKN1B, TET3, CD80, DRAM1, and ARID5B as Associated with Systemic Lupus Erythematosus in Asians","volume":"92","author":"Yang","year":"2013","journal-title":"Am J Hum Genet"},{"issue":"3","key":"10.1016\/j.ando.2020.04.002_bib0075","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/73144","article-title":"p27kip1 functions as an anergy factor inhibiting interleukin 2 transcription and clonal expansion of alloreactive human and mouse helper T lymphocytes","volume":"6","author":"Boussiotis","year":"2000","journal-title":"Nature Medicine"},{"issue":"2","key":"10.1016\/j.ando.2020.04.002_bib0080","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/art.37778","article-title":"p27Kip1 inhibits systemic autoimmunity through the control of Treg cell activity and differentiation","volume":"65","author":"Iglesias","year":"2013","journal-title":"Arth Rheumat"},{"issue":"4","key":"10.1016\/j.ando.2020.04.002_bib0085","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nri3625","article-title":"New roles for cyclin-dependent kinases in T cell biology: linking cell division and differentiation","volume":"14","author":"Wells","year":"2014","journal-title":"Nat Rev Immunol"},{"issue":"10","key":"10.1016\/j.ando.2020.04.002_bib0090","doi-asserted-by":"crossref","first-page":"T195","DOI":"10.1530\/ERC-17-0243","article-title":"MEN4 and CDKN1B mutations: the latest of the MEN syndromes","volume":"24","author":"Alrezk","year":"2017","journal-title":"Endocrine-Related Cancer"},{"issue":"8","key":"10.1016\/j.ando.2020.04.002_bib0095","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1210\/jc.2006-2843","article-title":"Germline CDKN1B\/p2 Kip1 Mutation in Multiple Endocrine Neoplasia","volume":"92","author":"Georgitsi","year":"2007","journal-title":"J Clin Endocrinol Metabol"},{"issue":"1","key":"10.1016\/j.ando.2020.04.002_bib0100","doi-asserted-by":"crossref","first-page":"3296","DOI":"10.1038\/s41467-018-05854-6","article-title":"The tumor suppressor menin prevents effector CD8 T-cell dysfunction by targeting mTORC1-dependent metabolic activation","volume":"9","author":"Suzuki","year":"2018","journal-title":"Nat Commun"}],"container-title":["Annales d'Endocrinologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426620300573?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426620300573?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T22:52:19Z","timestamp":1757717539000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003426620300573"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":10,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S0003426620300573"],"URL":"https:\/\/doi.org\/10.1016\/j.ando.2020.04.002","relation":{},"ISSN":["0003-4266"],"issn-type":[{"type":"print","value":"0003-4266"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multiple Endocrine Neoplasia Type 4: Novel CDNK1B variant and immune anomalies","name":"articletitle","label":"Article Title"},{"value":"Annales d'Endocrinologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ando.2020.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}